Company Filing History:
Years Active: 2015-2024
Title: Katsuhiro Kojima: Innovator in Biochemical Engineering
Introduction
Katsuhiro Kojima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemical engineering, particularly through his innovative patents. With a total of 8 patents, Kojima's work has advanced the understanding and application of enzyme technology.
Latest Patents
One of his latest patents is the "Fusion protein of flavin adenine dinucleotide-glucose dehydrogenase and cytochrome molecule." The purpose of this invention is to provide a fungus-derived FADGDH that has a direct electron transfer ability. This patent presents a fusion protein comprising a fungus-derived FADGDH or a mutant thereof, connected to a cytochrome molecule at the N-terminus of the FADGDH or its variant. Another notable patent is the "Mutant glucose oxidase and use thereof." This invention utilizes a mutant glucose oxidase with a specific amino acid sequence modification, allowing for the binding of an electron acceptor through a reactive functional group, resulting in an electron acceptor-modified glucose oxidase.
Career Highlights
Katsuhiro Kojima has worked with several reputable companies, including Arkray, Inc. and Ultizyme International Ltd. His experience in these organizations has contributed to his expertise in enzyme technology and biochemical innovations.
Collaborations
Throughout his career, Kojima has collaborated with notable professionals in the field, including Kazushige Mori and Koji Sode. These collaborations have further enriched his research and development efforts.
Conclusion
Katsuhiro Kojima's contributions to biochemical engineering through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations.